Aquilo is a small and flexible contract research organization (CRO) founded in 2015 as a spin-off company from the University of Groningen.

We are focused and specialized  in respiratory diseases such as asthma, COPD and lung fibrosis.

As a small company we are;

  • Focused and driven

  • Striving to deliver the best service and data packing to help our clients

  • Able to provide short communication lines

    and initiation times for new studies

  • Various packages of preclinical studies

    consisting of efficacy, target validation and mechanisms of action studies.


Did you know that Aquilo refers to the Roman god of the northern wind? This name was selected by the founders as Aquilo is based in the northern part of the Netherlands with the aim to contribute to therapies directed at airflow improvement in lung diseases.